testbiotech

Bilder

New GE salmon: Let’s talk about the risks!

Will salmon with artificially-induced genetic defects be released in Norway?

21 November 2023 / An application for the experimental release of salmon obtained from new genetic engineering (New GE, also new genomic techniques, NGT) was submitted in Norway in April 2023. This is the very first application in Europe. Now, a risk assessment of the genetically engineered salmon undertaken by Norwegian scientists came to a negative conclusion. CRISPR/Cas was used in the salmon to switch off the genes responsible for the development of the reproductive organs. The intention was to use the sterile salmon for fattening in aquaculture.

Risks of New GE: EU Commission in opposition to science

Concerns about planned deregulation backed by new research

9 November 2023 / Two recent scientific studies have reported surprising effects caused by CRISPR/Cas gene scissors applications in plants. The new findings are also important for the risk assessment of plants obtained from new genetic engineering (New GE, also known as new genomic techniques, NGT), and increase concerns about EU plans for deregulation.

Risks associated with plants obtained from 'new genetic engineering' are more complex than assumed

27 October 2023 / A new publication in the science journal ‘Frontiers in Bioengineering and Biotechnology’ comprehensively reviews unintended genetic changes in plants caused by new genetic engineering processes (or new genomic techniques, NGT). The study shows that the risks associated with NGT plants are frequently underestimated.

General Court of the European Union rejects lawsuits against approvals of transgenic plants

Testbiotech filed legal cases against EU Commission decisions

18 October 2023 / The General Court of the European Union today rejected two lawsuits against import approvals awarded to Bayer (T-605/21-8 and T-606/21-8) for genetically engineered plants. Testbiotech filed two legal cases against decisions made by the EU Commission to issue market approvals for genetically engineered soybeans and maize. According to Testbiotech, the risks associated with these transgenic plants have not been assessed as required by law.